Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,009 | 12 | 76.9% |
| Food and Beverage | $904.98 | 44 | 23.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $1,478 | 9 | $0 (2018) |
| Medtronic USA, Inc. | $1,061 | 14 | $0 (2017) |
| Nevro Corp. | $843.15 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $88.51 | 5 | $0 (2017) |
| AbbVie Inc. | $80.27 | 5 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $49.65 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $48.38 | 3 | $0 (2017) |
| Avanos Medical | $44.00 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $35.30 | 3 | $0 (2023) |
| Lilly USA, LLC | $31.06 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.46 | 3 | AbbVie Inc. ($29.77) |
| 2021 | $50.50 | 3 | AbbVie Inc. ($50.50) |
| 2019 | $843.15 | 3 | Nevro Corp. ($843.15) |
| 2018 | $103.97 | 4 | Avanos Medical ($44.00) |
| 2017 | $2,873 | 43 | Stryker Corporation ($1,443) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/02/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/01/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Travel and Lodging | In-kind items and services | $802.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/18/2018 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/24/2018 | Stryker Corporation | IVS - MULTIGEN RF (Device) | Food and Beverage | Cash or cash equivalent | $24.80 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/07/2018 | Avanos Medical | COOLIEF (Device) | Food and Beverage | In-kind items and services | $44.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/19/2018 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device), IVS - MULTIGEN RF | Food and Beverage | Cash or cash equivalent | $10.75 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 08/14/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DIABETES | ||||||
| 08/11/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: DIABETES | ||||||
| 07/25/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 07/20/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: DIABETES | ||||||
| 07/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Lower GI | ||||||
| 06/12/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: DIABETES | ||||||
| 06/10/2017 | Medtronic USA, Inc. | VECTRIS (Device) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/09/2017 | Medtronic USA, Inc. | KYPHON Balloon Kyphoplasty (Device) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 06/06/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Endocrinology | ||||||
| 06/03/2017 | Stryker Corporation | IVS - RF Cannulae/Needles (Device), IVS - Vertebral Augmentation Products | Travel and Lodging | Cash or cash equivalent | $115.08 | General |
| Category: Interventional Spine | ||||||
| 06/03/2017 | Stryker Corporation | IVS - RF Cannulae/Needles (Device), IVS - Vertebral Augmentation Products | Travel and Lodging | Cash or cash equivalent | $71.83 | General |
| Category: Interventional Spine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 107 | 200 | $63,374 | $14,930 |
| 2022 | 2 | 76 | 196 | $83,008 | $18,255 |
| 2021 | 6 | 294 | 550 | $224,868 | $52,240 |
| 2020 | 6 | 338 | 536 | $311,435 | $46,498 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 156 | $45,685 | $10,894 | 23.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $9,625 | $2,100 | 21.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $5,095 | $1,139 | 22.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 14 | $2,969 | $797.43 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 175 | $73,372 | $16,230 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 20 | 21 | $9,636 | $2,025 | 21.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 128 | 381 | $129,947 | $33,881 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 41 | $33,647 | $6,728 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 43 | 44 | $19,008 | $4,194 | 22.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 42 | 43 | $21,930 | $3,259 | 14.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 19 | 19 | $9,204 | $2,545 | 27.6% |
| 99218 | Hospital observation care, typically 30 minutes | Facility | 2021 | 21 | 22 | $11,132 | $1,634 | 14.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 91 | 192 | $102,235 | $16,104 | 15.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 84 | 178 | $76,461 | $10,356 | 13.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 60 | $58,387 | $10,212 | 17.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 72 | 73 | $46,943 | $6,191 | 13.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 19 | 19 | $22,059 | $2,795 | 12.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 14 | $5,350 | $839.30 | 15.7% |
About Hingwan Yu, D.O. & M.D
Hingwan Yu, D.O. & M.D is a Internal Medicine healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1861790487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hingwan Yu, D.O. & M.D has received a total of $3,914 in payments from pharmaceutical and medical device companies, with $42.46 received in 2023. These payments were reported across 56 transactions from 17 companies. The most common payment nature is "Travel and Lodging" ($3,009).
As a Medicare-enrolled provider, Yu has provided services to 815 Medicare beneficiaries, totaling 1,482 services with total Medicare billing of $131,923. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Sleep Medicine
- Location Flushing, NY
- Active Since 03/06/2011
- Last Updated 10/31/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861790487
Products in Payments
- IVS - Vertebral Augmentation Products (Device) $1,256
- KYPHON Balloon Kyphoplasty (Device) $1,024
- Senza Spinal Cord Stimulation System (Device) $843.15
- IVS - RF Cannulae/Needles (Device) $186.91
- TOUJEO (Drug) $71.02
- VRAYLAR (Drug) $50.50
- Amitiza (Drug) $49.65
- COOLIEF (Device) $44.00
- XARELTO (Drug) $35.30
- SPECIFY (Device) $33.73
- ANORO (Drug) $32.53
- TRULICITY (Drug) $31.06
- JARDIANCE (Drug) $29.51
- IVS - MULTIGEN RF (Device) $24.80
- Proclaim Family of SCS IPGs (Device) $24.42
- ENTRESTO (Drug) $24.05
- Prolia (Biological) $21.67
- LANTUS (Drug) $17.49
- HYSINGLA ER (Drug) $16.47
- QULIPTA (Drug) $16.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flushing
Calvin Pan, M.d, M.D
Internal Medicine — Payments: $975,186
Ari Bunim, Md, MD
Internal Medicine — Payments: $361,039
Glenn Turett, M.d, M.D
Internal Medicine — Payments: $231,558
Weining Liang, Md, MD
Internal Medicine — Payments: $180,077
Dr. Yong Yu, M.d, M.D
Internal Medicine — Payments: $144,144
Dr. John Sciales, M.d, M.D
Internal Medicine — Payments: $92,715